The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
The latest news from CDMOs, CMOs, and suppliers featuring WuXi Biologics, Catalent, Stevanato, Wasdell, and Evotec.
Chemicals/Chemical API Manufacturing
Evotec, leon-nanodrugs Enter Pact for Nanomedicine Evotec, a Hamburg, Germany-based...
The Janssen Pharmaceutical Companies of Johnson & Johnson (J&J) have signed separate agreements with Emergent BioSolutions, a Gaithersburg, Maryland-based specialty biopharmaceutical company and contract manufacturer, and Catalent for the...
The latest from CDMOs, CMOs, and suppliers in supporting COVID-19 efforts featuring MilliporeSigma, Cytiva, Emergent BioSolutions, Recipharm, Kaneka, Marken, Croda, and Wavelength Pharmaceuticals.
Chemicals/Chemical API Manufacturing
Kaneka To...
Merck KGaA has announced plans to invest EUR 100-million ($108-million) for a second commercial viral vector and gene-therapy manufacturing facility in Carlsbad, California for the CDMO service offerings of its life-science business. The new...
The latest news from CDMOs, CMOs, and suppliers featuring PharmaBlock Sciences, AGC Pharma Chemicals Europe, and Legacy Pharmaceutical Packaging.
Chemicals/Chemical API Manufacturing
PharmaBlock Launches Chemistry and Engineering Technology...
Samsung Biologics, a contract biologics manufacturer, and Vir Biotechnology, a San Francisco-based clinical-stage biopharmaceutical company, have formed a manufacturing agreement, valued at $362 million, under which Samsung Biologics will provide...
The latest news from CDMOs, CMOs, and suppliers featuring news from Univercells, Xellia, Aphena, and Cambrex.
Biologics Manufacturing
Univercells Launches CDMO Exothera Univercells, a technology company specializing in bioprocessing, has...
The latest from CDMOs, CMOs, and suppliers on supporting COVID-19 efforts featuring Cobra Biologics, Emergent Biosolutions, WuXi AppTec, Almac and Eurofins.
Biologics manufacturing
Cobra Biologics To Develop COVID-19 Vaccine Cobra Biologics, a...
Danaher, a global science and technology company, headquartered in Washington D.C., has completed its $21.4-billion acquisition of the biopharma business from General Electric’s Life Sciences division. As part of Danaher, the business will be...
The US Department of Health and Human Services (HHS) has launched a public–private partnership for high-speed, high-volume emergency drug-packaging using prefilled syringes and has awarded Apiject Systems America, a Stamford, Connecticut-based...
Thermo Fisher Scientific is investing more than $475 million in commercial capabilities and capacity in 2020 for biologics, cell and gene therapies, and drug products. This investment, in addition to those made in 2019, brings the total...
Fujifilm plans to invest approximately JPY 9 billion yen ($83 million) to expand microbial production capacity of Fujifilm Diosynth Biotechnologies (FDB), its CDMO of biologics, vaccines and gene therapies.
The expansion will triple FDB's...
Thermo Fisher Scientific has agreed to acquire Qiagen, a provider of molecular diagnostics and sample preparation technologies, for an approximate transaction value of $11.5 billion or EUR 39 ($44) per share.
The transaction values Qiagen at...
The latest news from CDMOs, CMOs, and suppliers featuring news from Dipharma, Fujifilm Diosynth Biotechnologies, Univercells, and Aphena Pharma Solutions.
Chemicals/Chemical API Manufacturing
Dipharma Completes Construction of New cGMP Suite in...
WuXi Vaccines, a vaccine CDMO and joint venture between WuXi Biologics and Shanghai Hile Bio-technology, has entered into a strategic partnership with an undisclosed global vaccine company and signed a 20-year vaccine manufacturing contract...
